adjuvant treatment

Receive alerts:
by e-mail
E-mail Your information will be added to a database with the sole purpose of serving your subscription. This database is the exclusive property of vLex Networks S.L. and will never be shared with any other company. By sending your request you accept the Data Protection Policy of vLex Networks S.L. I have read and accept the Terms of Use
via RSS

1.481 documents for adjuvant treatment

- Successful adjuvant treatment of recalcitrant mucous membrane pemphigoid with anti-CD20 antibody rituximab.
Abstract Rituximab is a humanized monoclonal antibody directed against CD20-positive B cells and originally developed for the treatment of non-Hodgk...
- Journal of Drugs in Dermatology
- Vol. 6 Nbr. 7, July 2007
- For the Adjuvant Treatment of NSCLC, the Highest Proportion of Surveyed MCOs Select Paclitaxel/Carboplatin and Docetaxel/Cisplatin as Having the Best Overall Clinical Profile Compared to Other Currently Available Therapies.
However, Compared With Surveyed Oncologists, Surveyed MCO Pharmacy Directors Indicate Less Satisfaction With Paclitaxel/Carboplatin and Docetaxel/Cisp...
- Business Wire
- January 13, 2011
- Government-Owned Inventions; Availability for Licensing
The inventions listed below are owned by an agency of the U.S. Government and are available for licensing in the U.S. in accordance with 35 U.S.C. 207 to achieve expeditious commercialization of results of federally-funded research and development. Foreign patent applications are filed on selected inventions to extend market coverage for companies and may also be available for licensing.

...Treatment of Tuberculosis--Adjuvant Therapies To Increase th...
- Federal Register Nbr. 76 FR 72713, November 25, 2011
- Notices
- National Institutes of Health

- Local immune modulator (imiquimod 5% cream) as adjuvant treatment after incomplete mohs micrographic surgery for large, mixed type basal cell carcinoma: a report of 3 cases.
Abstract Background: Surgical excision, including Mohs micrographic surgery, is the treatment of first choice for basal cell carcinoma (BCC). Occasi...
- Journal of Drugs in Dermatology
- Vol. 5 Nbr. 5, May 2006
- Life Sciences Newsbriefs: Week Of March 5, 2012 (Part 2)
... with Januvia, an approved diabetes treatment. Merck was supposed to meet the postmarket require... Glivec, allowing as long as 36 months of adjuvant treatment among adults with KIT (CD117)-positive g...
- Mondaq Business Briefing
- United States Law Articles in English
- OSI Pharmaceuticals Launches Study of Tarceva(R) as Adjuvant Treatment for Non-Small Cell Lung Cancer.
MELVILLE, N.Y. -- OSI Pharmaceuticals, Inc. (Nasdaq: OSIP) announced today that it has begun a Phase III clinical trial of Tarceva(R) (erlotinib) as a...
- Business Wire
- September 21, 2006
- A review of the chemopreventative effects of oral retinoids for internal neoplasms.
... is a growing concern in the systemic treatment of psoriasis. . Cancer chemoprevention is a concep... treated with isotretinoin in the adjuvant setting.(24) The study randomized 103 patients wit...
- Journal of Drugs in Dermatology
- Vol. 10 Nbr. 11, November 2011
- Study Backs Radiation for Ductal Breast Cancer
Women who undergo breast-conserving surgery to treat the most common type of non-invasive breast cancer could cut the risk of recurrence by adding radiation and drug therapy to their treatment, according to a study conducted by the National Surgical Adjuvant Breast and Bowel Project based at Allegheny General Hospital in Pittsburgh. The study should reassure women with ductal carcinoma in situ that, after a lumpectomy, additional countermeasures such as radiation are not necessarily an indication of overtreatment, said Dr. Thomas Julian, principal investigator of the study, published today in the Journal of the National Cancer Institute. In DCIS, which accounts for 25 percent of breast cancer diagnoses, cancer cells are lodged in the breast ducts without invading other breast tissues.
- Tribune - Review / Pittsburgh Tribune - Review
- March 16, 2011
- A Glossary: ; of Cancer Terms
Adjuvant therapy: Treatment used along with primary treatment Aggressive: Fast-growing cancer
- Charleston Gazette
- November 11, 2004
- Life Sciences Newsbriefs: Week Of March 5, 2012 (Part 2).
... with Januvia, an approved diabetes treatment. Merck was supposed to meet the postmarket require... Glivec, allowing as long as 36 months of adjuvant treatment among adults with KIT (CD117)-positive g...
- Mondaq Business Briefing
- Nbr. 2012, January 2012